Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

T Cell Types and Functions01:24

T Cell Types and Functions

3.2K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
3.2K
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

35
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
35

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Psychedelics and autism spectrum disorder: Mechanistic insights, translational evidence and ethical challenges.

Journal of psychiatric research·2026
Same author

Hospital-treated infection associated with Alzheimer's disease pathology: underlying mechanisms.

Molecular psychiatry·2026
Same author

Assessing the Sylvatic Yellow Fever Vectors in Southern Brazil.

Insects·2026
Same author

Impact of prenatal LPS on sepsis-related neurobiological outcomes.

Metabolic brain disease·2026
Same author

The effects of neuromodulation through brainwave entrainment on pain in women with fibromyalgia: a randomized controlled clinical trial with Follow-Up.

Pain medicine (Malden, Mass.)·2026
Same author

Aedes aegypti salivary gland extract enhances Zika virus replication through immune modulation.

Memorias do Instituto Oswaldo Cruz·2026
Same journal

Pre-Treatment with Estradiol, But not Progesterone, Exacerbates DSS Colitis: Dysregulated Innate Immunity and Impaired Epithelial Damage Response.

Inflammation·2026
Same journal

ORMDL3 as Key Regulator of Endothelial Dysfunction in Atherosclerosis via Sphingolipid Biosynthesis.

Inflammation·2026
Same journal

Opposing Dynamics of CD4 + Regulatory and CD8 + Foxp3+ T Cells Characterize Immune Imbalance in Rheumatoid Arthritis.

Inflammation·2026
Same journal

The Dual Role of Exosomes in Gout: From Inflammatory Amplifiers to Therapeutic Regulators.

Inflammation·2026
Same journal

Integrated Multi-omics Profiling of 2,4-dinitrochlorobenzene (DNCB)-induced Atopic Dermatitis in Mice Reveals a Coordinated Network of Barrier Dysfunction, Immune Activation, and Metabolic Reprogramming.

Inflammation·2026
Same journal

A Dynamic and Complex Early Inflammatory Response in Blood and Cerebrospinal Fluid of Severe Traumatic Brain Injury Patients: A Dual Platform Analysis.

Inflammation·2026
See all related articles

Related Experiment Video

Updated: May 5, 2026

The Application Of Permanent Middle Cerebral Artery Ligation in the Mouse
08:27

The Application Of Permanent Middle Cerebral Artery Ligation in the Mouse

Published on: July 25, 2011

19.6K

IL-33 in Ischemic Stroke: Brain vs. Periphery.

Khiany Mathias1,2, Richard Simon Machado1,2, Anita Dal Bó Tiscoski1

  • 1Laboratory of Experimental Neurology, Health Sciences Unit, Graduate Program in Health Sciences, University of Southern Santa Catarina, Criciuma, SC, Brazil.

Inflammation
|September 18, 2024
PubMed
Summary
This summary is machine-generated.

Interleukin-33 (IL-33) shows protective effects against ischemic stroke-induced brain injury by modulating immune responses and inflammation. This review explores IL-33

Keywords:
ImmunosuppressionInflammationInterleukin-33Ischemic stroke

More Related Videos

Isolation and Flow Cytometric Analysis of Immune Cells from the Ischemic Mouse Brain
12:14

Isolation and Flow Cytometric Analysis of Immune Cells from the Ischemic Mouse Brain

Published on: February 12, 2016

34.9K
Two-vessel Occlusion Mouse Model of Cerebral Ischemia-reperfusion
07:34

Two-vessel Occlusion Mouse Model of Cerebral Ischemia-reperfusion

Published on: March 1, 2019

11.7K

Related Experiment Videos

Last Updated: May 5, 2026

The Application Of Permanent Middle Cerebral Artery Ligation in the Mouse
08:27

The Application Of Permanent Middle Cerebral Artery Ligation in the Mouse

Published on: July 25, 2011

19.6K
Isolation and Flow Cytometric Analysis of Immune Cells from the Ischemic Mouse Brain
12:14

Isolation and Flow Cytometric Analysis of Immune Cells from the Ischemic Mouse Brain

Published on: February 12, 2016

34.9K
Two-vessel Occlusion Mouse Model of Cerebral Ischemia-reperfusion
07:34

Two-vessel Occlusion Mouse Model of Cerebral Ischemia-reperfusion

Published on: March 1, 2019

11.7K

Area of Science:

  • Neuroscience
  • Immunology
  • Cardiovascular Research

Background:

  • Cerebrovascular disease, particularly ischemic stroke, is a leading global cause of death and disability.
  • Ischemic stroke triggers immunosuppression, increasing infection susceptibility and impacting neuroinflammation.
  • Interleukin-33 (IL-33), an IL-1 family member, is a key immune response and inflammation modulator.

Purpose of the Study:

  • To review the role and impact of IL-33 on immune system mechanisms following ischemic stroke.
  • To highlight IL-33's potential as a therapeutic target for stroke-related brain injury.

Main Methods:

  • Comprehensive review of preclinical and clinical studies.
  • Analysis of IL-33's function in modulating inflammatory cytokines.
  • Examination of IL-33's role in stimulating immune regulatory cells.

Main Results:

  • IL-33 demonstrates a protective effect on brain injury post-ischemic stroke.
  • IL-33 influences the balance of immune responses and inflammation in the context of stroke.
  • Modulation of inflammatory cytokines and immune cells by IL-33 is crucial for neuroprotection.

Conclusions:

  • IL-33 is a significant factor in the immune response following ischemic stroke.
  • IL-33 represents a promising therapeutic target for mitigating stroke-induced brain damage and associated immune dysregulation.